The neuropathologic basis of different clinical subgroups of Parkinson's disease
- PMID: 1748881
- DOI: 10.1097/00005072-199111000-00006
The neuropathologic basis of different clinical subgroups of Parkinson's disease
Abstract
Clinical and neuropathologic data in 45 patients with Parkinson's disease (PD) were compared. Twenty-seven patients suffered from marked akinesia and rigidity (AR-type) and 18 patients from predominant resting tremor (T-type). Dementia, depression, and psychosis occurred in 26, 18, and 18 patients, respectively. Neuronal counts were performed in defined areas of the medial and lateral substantia nigra (SNM, SNL), locus ceruleus (LC), and dorsal raphe nucleus (DRN). The AR-type (compared with the T-type) showed higher neuronal loss of LC, SNL, SNM, and more severe gliosis, extraneuronal melanin deposits, and neuroaxonal dystrophy in substantia nigra. Demented PD patients showed more intense cortical Alzheimer lesions and higher neuronal depletion in the SNM, whereas PD subjects with moderate or marked dementia differed from mildly or not demented ones only in the higher degree of cortical Alzheimer lesions. More severe neuronal cell loss of DRN was observed in PD patients with depression. Occurrence of psychosis was not associated with any pathologic feature. Our findings indicate that some major clinical features of PD are related to distinct neuropathologic lesions.
Similar articles
-
Clinico-pathological correlations in Parkinson's disease.Clin Neurol Neurosurg. 1992;94 Suppl:S86-8. doi: 10.1016/0303-8467(92)90033-y. Clin Neurol Neurosurg. 1992. PMID: 1320531
-
The locus ceruleus and dementia in Parkinson's disease.Neurology. 1993 May;43(5):986-91. doi: 10.1212/wnl.43.5.986. Neurology. 1993. PMID: 8492957
-
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.Arch Neurol. 2003 Mar;60(3):337-41. doi: 10.1001/archneur.60.3.337. Arch Neurol. 2003. PMID: 12633144
-
The relationship of Alzheimer-type pathology to dementia in Parkinson's disease.J Neural Transm Suppl. 1997;49:23-31. doi: 10.1007/978-3-7091-6844-8_3. J Neural Transm Suppl. 1997. PMID: 9266411 Review.
-
Neuropathological substrates of Alzheimer's disease and Parkinson's disease.J Neural Transm Suppl. 1987;24:109-29. J Neural Transm Suppl. 1987. PMID: 3316494 Review.
Cited by
-
Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21. Neurobiol Dis. 2015. PMID: 26102022 Free PMC article.
-
The pathobiological basis of depression in Parkinson disease: challenges and outlooks.J Neural Transm (Vienna). 2022 Dec;129(12):1397-1418. doi: 10.1007/s00702-022-02559-5. Epub 2022 Nov 2. J Neural Transm (Vienna). 2022. PMID: 36322206 Free PMC article. Review.
-
Neural and behavioral substrates of subtypes of Parkinson's disease.Front Syst Neurosci. 2013 Dec 24;7:117. doi: 10.3389/fnsys.2013.00117. Front Syst Neurosci. 2013. PMID: 24399940 Free PMC article. Review.
-
Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.Brain Pathol. 2014 Apr;24(3):247-60. doi: 10.1111/bpa.12115. Epub 2014 Mar 3. Brain Pathol. 2014. PMID: 24779419 Free PMC article.
-
Depression in dementia with Lewy bodies: a critical update.J Neural Transm (Vienna). 2023 Oct;130(10):1207-1218. doi: 10.1007/s00702-023-02669-8. Epub 2023 Jul 7. J Neural Transm (Vienna). 2023. PMID: 37418037 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous